Indefinite Delivery Contract 75D30125D00194
Award Date
4/1/25
Last Date to Order
3/30/26
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024.
The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to provide a variety of standard pediatric vaccines to support immunization programs under the Vaccines for Children program and Section 317(j) of the Public Health Service Act. The IDC has a ceiling value of $1,598,247,500 and a period of performance from April 1, 2021 through March 31, 2022. It was...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of 27 different pediatric vaccines to support the CDC's Immunization Awardees program and Vaccines for Children program. The contract has a period of performance from April 1, 2024 to March 31, 2025 and a ceiling value of $1,914,795,500.00.
The solicitation sought offers for the supply of...
The federal contract IDV award is an Indefinite Delivery Contract issued by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC (Merck) to supply standard commercial pediatric vaccines for the Vaccines for Children (VFC) program. The $4.116 billion contract has an ultimate completion date of March 30, 2026, supporting critical immunization initiatives under the VFC program and adult vaccination efforts per Section 317(j) of the Public Health Service Act. Merck,...
This federal contract IDV award was issued by the Centers for Disease Control and Prevention (CDC) to procure pediatric vaccines for the Vaccines for Children (VFC) program. The 5-year, $1.35 billion multiple award contract aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The prime contractor,...
This federal contract IDV was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. as the prime contractor. It is an indefinite delivery, indefinite quantity (IDIQ) contract with a ceiling value of $1,681,772,750 for the procurement of up to 23 standard pediatric vaccines over a 1-year period of performance from April 1, 2022 to March 31, 2023. The vaccines will support the CDC's Immunization Awardees and Vaccine for Children (VFC) program, which provides...
This federal contract IDV is awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to procure a range of pediatric vaccines for the agency's Immunization Awardees program and Vaccines for Children program. The 5-year, $1.3 billion multiple award contract enables the CDC to purchase between 100 doses and 13 million doses of 27 different pediatric vaccines from the prime contractor, Glaxosmithkline, LLC. The vaccines...
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to support pediatric immunization programs. The contract holder will provide up to 23 standard pediatric vaccines to CDC without a set-aside designation. Vaccines must be manufactured under current FDA licensure with a minimum 12-month shelf life.
The multiple award IDV has a potential value of $1.5B to be ordered by March 2023 for delivery within the United...
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to support the Vaccines for Children program and Section 317(j) of the Public Health Service Act. The prime contractor is Sanofi Pasteur Inc. The contract has a potential value of $1.537 billion and a period of performance from April 1, 2021 through March 31, 2022.
Under this IDV, the contractor will provide 20 standard pediatric vaccines to support...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc. for the procurement of standard commercial COVID-19 vaccines with a pediatric indication for children aged 0 through 18 years. The contract has a $1,075,250,000.00 ceiling value and a performance period ending on June 6, 2024.
The vaccines procured under this multiple-award IDC will support pediatric immunization programs through the Vaccines...